OptimizeRx’s Steve Silvestro Honored as Transformational Leader in Healthcare by PM360
07 Mai 2020 - 10:01PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies and payers, announced
its chief commercial officer, Steve Silvestro, has been honored
with the 2020 PM360 ELITE 100 Award for his organizational
leadership and positive impact on the healthcare industry.
The annual awards program recognizes the 100 most influential
people in the healthcare industry as the ELITE, which stand for
Exceptional Leaders, Innovators, Transformers, and Entrepreneurs.
The award is sponsored by PM360, the premier magazine and online
news source for marketing decision makers in the pharmaceutical,
biotech, and medical device industries.
PM360 received hundreds of nominations which were evaluated and
selected by the PM360 editorial staff based on accomplishments,
testimonials, and supporting evidence that reflected the impact of
their efforts.
Silvestro was recognized in the Transformational Leaders
category for his exceptional ability to foster positive
organizational change, with his profile featured on the PM360 ELITE
100 website and in the publication’s May 2020 issue.
“This well-deserved award reflects Steve’s career-long
commitment to improving outcomes for all stakeholders in
healthcare, from patient and doctors, to organizations that provide
life-saving medications and treatments,” commented OptimizeRx CEO,
William Febbo. “Steve has become a trusted advisor to our clients
on key strategic initiatives, a mentor among his peers, and a
valuable member of our executive team. He has earned deep respect
within our organization for his transformational work that has
driven the growth and market expansion of our OptimizeRx digital
health platform and our ability to deliver the best in connected
care.”
CEO and publisher of PM360, Anna Stashower, stated: “At a time
when the world is being impacted by a healthcare crisis in the
COVID-19 pandemic, it is nice to be able to reflect on the
extraordinary work those in the life sciences do to discover,
develop, and promote life-saving treatments. Our ELITE winners
epitomize the very best of our industry. We are incredibly thankful
for everything they do and proud to honor all of their
achievements.”
See Steve Silvestro’s PM360 ELITE 100 profile here, and more
information about the PM360 ELITE 100 Award at
pm360online.com/the-2020-pm360-elite-100.
About OptimizeRx®OptimizeRx Corporation
(NASDAQ: OPRX) is a digital health company that facilitates
communication at point-of-care among all stakeholders in
healthcare. Primarily focused on life science and payer clients,
its suite of digital and mobile SaaS-based solutions enables
affordability, patient adherence and care management. OptimizeRx’s
network reaches more than 60% of U.S. ambulatory providers,
delivering therapeutic support on specialty medications and patient
financial assistance directly within a provider’s workflow through
leading electronic health platforms. OptimizeRx’s fully integrated
platform supports the real-time exchange of information, improving
provider knowledge and patient engagement, and ultimately leading
to healthier outcomes.
For more information, follow the company on Twitter, LinkedIn or
visit www.OptimizeRx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira Alejandra, Media
Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both, CMATel
(949) 432-7557 oprx@cma.team
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/78a26765-8a58-4772-9e4e-7293c085104b
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024